98%
921
2 minutes
20
Introduction: Pyruvate dehydrogenase complex (PDH) deficiency (Online Mendelian Inheritance in Man # 312170) is a relatively common mitochondrial disorder, caused by mutations in the X-linked gene and presenting with a variable phenotypic spectrum, ranging from severe infantile encephalopathy to milder chronic neurological disorders.Isolated peripheral neuropathy as predominant clinical presentation is uncommon.
Results: We report on a patient, now 21 years old, presenting at the age of 2 years with recurrent symmetric weakness as first symptom of a PDH deficiency. Neurophysiological evaluation proving a sensory-motor polyneuropathy with conduction blocks and presence of elevated cerebrospinal fluid proteins, suggested a chronic inflammatory demyelinating polyneuropathy. The evidence of high serum lactate and the alterations in oxidative metabolism in muscle biopsy pointed toward the final diagnosis. After starting nutritional supplements, no further episodes occurred. A hemizygous mutation in (p.Arg88Cys) was identified. This mutation has been previously described in five patients with a similar phenotype. A three-dimensional reconstruction demonstrated that mutations affecting this arginine destabilize the interactions between the subunits of the E1 complex.
Conclusion: We summarize the clinical and genetic characteristics of one patient with PDH deficiency presenting isolated peripheral nervous system involvement. This study highlights that the diagnosis of PDH deficiency should be considered in children with unexplained peripheral neuropathy, even with features suggestive of acquired forms, especially in case of early onset and limited response to treatment. A simple analysis of lactic acid could help to target the diagnosis.In addition, we suggest that the residue Arg88 is the most frequently involved in this specific phenotype of PDH deficiency.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/a-2018-4845 | DOI Listing |
J Biol Chem
August 2025
State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China; Department of Biochemistry & Molecular Biology, School of Life Sciences, China Medical University, Shenyang, China; University of Chinese Academy of Science
The activation of oncogenes is often accompanied by metabolic adaptations. The DNA/RNA-binding protein, Y-box binding protein 1 (YBX1), a well-known oncogene, is hyperactivated in nearly all cancer types. However, the metabolic hallmarks associated with YBX1 and the underlying mechanisms remain poorly understood.
View Article and Find Full Text PDFCureus
May 2025
Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, JPN.
The patient was a 24-year-old female with pyruvate dehydrogenase complex deficiency and cerebral palsy. At 14 years of age, she developed short bowel syndrome due to intestinal obstruction and began receiving total parenteral nutrition (TPN) at home. At 15 years of age, the patient developed intestinal failure associated with liver disease.
View Article and Find Full Text PDFBMC Genomics
May 2025
College of Life Science and Technology, Gansu Agricultural University, Lanzhou, 730070, China.
Background: Alfalfa (Medicago sativa L.) has the benefits of high yield and nutritional value as a sustainable forage. However, the water deficit significantly limits its growth and yield performance.
View Article and Find Full Text PDFJ Nutr Biochem
September 2025
School of Life Science and Technology, ShanghaiTech University, Shanghai, China; Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. Electronic address:
Methionine restriction diet has been extensively studied for its beneficial effects on metabolic health and aging. However, the impact of methionine deprivation on glucose metabolism per se and macrophage functions remains incompletely understood. In this study, we analyzed the functional roles of methionine deprivation on glucose flux and macrophage polarization.
View Article and Find Full Text PDFMol Genet Metab
June 2025
Department of Clinical Genomics, Saitama Medical University, Saitama, Japan.
BOLA3 is one of the proteins involved in the assembly and transport of [4Fe-4S] clusters, which are incorporated into mitochondrial respiratory chain complexes I and II, aconitase, and lipoic acid synthetase. Pathogenic variants in the BOLA3 gene cause a rare condition known as multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, characterized by life-threatening lactic acidosis, nonketotic hyperglycinemia, and hypertrophic cardiomyopathy. The aim of this study was to elucidate the biochemical characteristics of patients with BOLA3 variants and to clarify the role of BOLA3 protein in humans.
View Article and Find Full Text PDF